Search

everythinglearnresearchcommunity

for

Search:↓

The conclusion is that a new test was created to find substances that affect specific ion channels, and it works well for drug discovery.

Triphenylphosphine oxide can increase oil production and reduce inflammation in skin cells without affecting TRPM5.

TRPM5 is crucial for maintaining hair growth.

Combining ATRA with TPO-RA effectively stabilizes platelet counts in ITP patients.

The MBTPS2 gene variant c.970+5G>A is a common mutation causing IFAP syndrome.

TPA is about 50 times more effective at promoting tumors than MZ.

The Itpr3 gene causes a specific hair pattern in mice.

Early diagnosis and treatment of TPP can prevent complications.

HOTTIP and miR-10b contribute to glioma therapy resistance by affecting cell behavior, suggesting they could be targets for treatment.

MEGA PROTAC improves prediction and ranking of protein complexes better than existing methods.

3D-printed microneedles improve drug delivery and diagnostics but face scalability and regulatory challenges.

TTNPB helps turn stem cells into neural stem cells, improving depression-like behaviors in rats.

mrp/plf-mRNA can indicate tumor-promoting effects in skin.

Some patients on anti-TNF drugs experience a type of hair loss called TAIAPA.

Some drugs for inflammation may cause psoriasis-like hair loss.

Overexpression of PKCepsilon leads to increased TNFalpha, promoting metastatic squamous cell carcinoma in mice.

The report expanded knowledge of MBTPS1-related disorders by identifying new symptoms.

The hamster polyomavirus middle T antigen is linked to tumors in hamsters and associates with a specific tyrosine kinase.

Overexpressing the Tβ4 gene in goats can increase cashmere production.

Overexpressing Tβ4 in cashmere goats improves hair fiber traits and increases cashmere yield.

Temozolomide can cause severe bone marrow suppression, leading to life-threatening complications.

Some medications for inflammation can cause a condition with scalp rashes and hair loss, often linked to Crohn's disease, and may require treatment changes to prevent permanent hair loss.

Tofacitinib is a promising treatment for children with rheumatic diseases.

A Japanese patient with IFAP syndrome had a severe MBTPS2 gene mutation but showed milder symptoms than previously observed cases.

Some thymic peptides can increase human hair growth, while others may inhibit it.

Too much parathyroid hormone-related protein in skin disrupts hair growth in mice.

TIP39 and PTH2R help control calcium levels and skin cell development.

A standardized scoring system is needed to improve model reliability for predicting hair loss in brain tumor patients treated with proton therapy.

Sacituzumab tirumotecan shows promise in treating breast cancer with manageable side effects.

PROTACs offer new ways to treat hard-to-target diseases, with promising drugs for cancer in advanced trials.